Language selection

Government of Canada / Gouvernement du Canada

Search

New drug pipeline monitor.: H79-5E-PDF

"The New Drug Pipeline Monitor (NDPM) provides information on drugs currently under development that may have an impact on future drug plan expenditures in Canada. This publication contains a select list of pipeline drugs that are in Phase III clinical trials or under review by the US Food and Drug Administration (FDA) and that demonstrate the potential to have a significant clinical impact. The BioPharm Insight database is the main data source for this drug selection"--Executive summary, 2014.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.507462&sl=0

Publication information
Department/Agency
  • Canada. Patented Medicine Prices Review Board.
TitleNew drug pipeline monitor.
Publication typePeriodical
Language[English]
Other language editions[French]
Continued byMeds pipeline monitor ... ; 2562-3834 ; Began with 2018.
FormatDigital text
Note(s)
  • "National Prescription Drug Utilization Information System (NPDUIS)."
  • Issued also in French under title: L'observateur des médicaments émergents.
Publishing information
  • Ottawa, ON : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, 2007-2015.
ChronologyBegan with 2007; ceased with 2015.
FrequencyAnnual (Irregular)
ISSN2292-3136
Catalogue number
  • H79-5E-PDF
Subject terms
IssuesClick here to expand all
2015 Click to expand
2014 Click to expand
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: